全文获取类型
收费全文 | 4274篇 |
免费 | 296篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 95篇 |
妇产科学 | 118篇 |
基础医学 | 550篇 |
口腔科学 | 114篇 |
临床医学 | 726篇 |
内科学 | 907篇 |
皮肤病学 | 55篇 |
神经病学 | 314篇 |
特种医学 | 100篇 |
外科学 | 351篇 |
综合类 | 50篇 |
一般理论 | 4篇 |
预防医学 | 457篇 |
眼科学 | 40篇 |
药学 | 365篇 |
中国医学 | 2篇 |
肿瘤学 | 299篇 |
出版年
2023年 | 23篇 |
2022年 | 43篇 |
2021年 | 68篇 |
2020年 | 54篇 |
2019年 | 95篇 |
2018年 | 94篇 |
2017年 | 52篇 |
2016年 | 73篇 |
2015年 | 81篇 |
2014年 | 105篇 |
2013年 | 177篇 |
2012年 | 265篇 |
2011年 | 284篇 |
2010年 | 177篇 |
2009年 | 159篇 |
2008年 | 249篇 |
2007年 | 253篇 |
2006年 | 272篇 |
2005年 | 242篇 |
2004年 | 223篇 |
2003年 | 190篇 |
2002年 | 203篇 |
2001年 | 93篇 |
2000年 | 84篇 |
1999年 | 68篇 |
1998年 | 50篇 |
1997年 | 55篇 |
1996年 | 41篇 |
1995年 | 29篇 |
1994年 | 30篇 |
1993年 | 13篇 |
1992年 | 59篇 |
1991年 | 40篇 |
1990年 | 46篇 |
1989年 | 53篇 |
1988年 | 35篇 |
1987年 | 49篇 |
1986年 | 70篇 |
1985年 | 50篇 |
1984年 | 35篇 |
1983年 | 31篇 |
1982年 | 22篇 |
1981年 | 24篇 |
1980年 | 22篇 |
1979年 | 33篇 |
1977年 | 13篇 |
1975年 | 14篇 |
1974年 | 21篇 |
1973年 | 21篇 |
1970年 | 19篇 |
排序方式: 共有4591条查询结果,搜索用时 15 毫秒
71.
72.
73.
The Effect of Radiation on Complication Rates and Patient Satisfaction in Breast Reconstruction using Temporary Tissue Expanders and Permanent Implants 下载免费PDF全文
Christopher J. Anker MD Richard V. Hymas MD PhD Ravinder Ahluwalia MD Kristine E. Kokeny MD Vilija Avizonis MD Kenneth M. Boucher PhD Leigh A. Neumayer MD Jayant P. Agarwal MD 《The breast journal》2015,21(3):233-240
The optimal method of reconstruction following mastectomy for breast cancer patients receiving radiation therapy (RT) is controversial. This study evaluated patient satisfaction and complication rates among patients who received implant‐based breast reconstruction. The specific treatment algorithm analyzed included patients receiving mastectomy and immediate temporary tissue expander (TE), followed by placement of a permanent breast implant (PI). If indicated, RT was delivered to the fully expanded TE. Records of 218 consecutive patients with 222 invasive (85%) or in situ (15%) breast lesions from the Salt Lake City region treated between 1998 and 2009 were retrospectively reviewed, 28% of whom received RT. Median RT dose was 50.4 Gy, and 41% received a scar boost at a median dose of 10 Gy. Kaplan–Meier analyses were performed to evaluate the cumulative incidence of surgical complications, including permanent PI removal. Risk factors associated with surgical events were analyzed. To evaluate cosmetic results and patient satisfaction, an anonymous survey was administered. Mean follow‐up was 44 months (range 6–144). Actuarial 5‐year PI removal rates for non‐RT and RT patients were 4% and 22%, respectively. On multivariate analysis (MVA), the only factor associated with PI removal was RT (p = 0.009). Surveys were returned describing the outcomes of 149 breasts. For the non‐RT and RT groups, those who rated their breast appearance as good or better were 63% versus 62%, respectively. Under 1/3 of each group was dissatisfied with their reconstruction. RT did not significantly affect patient satisfaction scores, but on MVA RT was the only factor associated with increased PI removal. This reconstruction technique may be considered an acceptable option even if RT is needed, but the increased complication risk with RT must be recognized. 相似文献
74.
Kenneth A. Brown MD Charles A. Boucher MD Robert D. Okada MD H.William Strauss MD Kenneth A. McKusick MD Gerald M. Pohost MD 《The American journal of cardiology》1982,50(6):1217-1222
The relation of the appearance of the right ventricle on serium thallium-201 myocardial imaging to coronary artery anatomy was examined in 88 consecutive patients undergoing exercise thallium-201 testing and coronary angiography for the evaluation of chest pain. Transient defects in the right ventricle were found in 8 patients. All had high grade (≥ 90 %) stenosis of the proximal right coronary artery. Nonvisualization of right ventricular (RV) activity occurred in 10 patients. Nine of the 10 (90%) had significant (>- 50% stenosis) disease of the proximal right coronary artery and 7 (70%) had high grade stenosis. The right ventricle appeared normal in 70 patients. Twenty-nine (41 %) of these patients had significant proximal right coronary artery disease. Right ventricular appearance was not affected by the presence or absence of disease of the left anterior descending or left circumflex artery or by the appearance of the left ventricle.
Thus, with serial RV thallium-201 myocardial imaging after exercise, we found that (1) RV transient defects suggest the presence of high grade proximal right coronary artery stenosis, (2) nonvisualization of RV activity also predicts significant proximal right coronary disease, and (3) the right ventricle frequently appears normal despite proximal right coronary artery disease and therefore this finding does not exclude such disease. 相似文献
75.
Jakkula M Boucher TA Beyendorff U Conn SM Johnson JE Nolan CJ Peine CJ Albrecht JH 《Archives of internal medicine》2004,164(12):1341-1346
BACKGROUND: Many patients with the hepatitis C virus (HCV) cannot be successfully treated with interferon-based regimens. Chinese herbal medicines have been widely prescribed for HCV in Asia, and many infected patients in the United States have used these agents. However, data to support the efficacy of these medications are limited and, to our knowledge, no published trials have been conducted in a US population. METHODS: In a double-blinded design, 45 patients with HCV and fatigue were randomized to receive a combination of Chinese herbal medications or a matched placebo for 12 weeks. The main outcome measures were changes in health-related quality of life using the role physical and vitality scale scores from the validated Hepatitis Quality of Life Questionnaire and alanine aminotransferase levels. In addition, other Hepatitis Quality of Life Questionnaire variables, HCV load, and adverse effects were monitored. RESULTS: In patients with HCV, the herbal medications had no effect on any quality-of-life variables, as measured by the Hepatitis Quality of Life Questionnaire. In addition, no significant changes in alanine aminotransferase or serum HCV RNA levels were noted. No significant adverse effects were observed. CONCLUSIONS: In this study, a regimen of Chinese herbal medicines did not improve quality of life, liver chemistry results, or viral load in a cohort of patients with HCV. Patients and practitioners should remain cautious about the use of herbal medicines for HCV, because studies have not shown a clear benefit of these agents. 相似文献
76.
77.
78.
79.
Angelos Hatzakis Jeffrey V. Lazarus Evangelos Cholongitas Ricardo Baptista‐Leite Charles Boucher Cristian‐Silviu Busoi Sylvie Deuffic‐Burban Jagpreet Chhatwal Gamal Esmat Sharon Hutchinson Minerva‐Melpomeni Malliori Mojca Maticic Antons Mozalevskis Francesco Negro George A. Papandreou George V. Papatheodoridis Markus Peck‐Radosavljevic Homie Razavi Tatjana Reic Eberhard Schatz Nurdan Tozun Zobair Younossi Michael P. Manns 《Liver international》2020,40(2):260-270
The majority of people infected with chronic hepatitis C virus (HCV) in the European Union (EU) remain undiagnosed and untreated. During recent years, immigration to EU has further increased HCV prevalence. It has been estimated that, out of the 4.2 million adults affected by HCV infection in the 31 EU/ European Economic Area (EEA) countries, as many as 580 000 are migrants. Additionally, HCV is highly prevalent and under addressed in Eastern Europe. In 2013, the introduction of highly effective treatments for HCV with direct‐acting antivirals created an unprecedented opportunity to cure almost all patients, reduce HCV transmission and eliminate the disease. However, in many settings, HCV elimination poses a serious challenge for countries’ health spending. On 6 June 2018, the Hepatitis B and C Public Policy Association held the 2nd EU HCV Policy summit. It was emphasized that key stakeholders should work collaboratively since only a few countries in the EU are on track to achieve HCV elimination by 2030. In particular, more effort is needed for universal screening. The micro‐elimination approach in specific populations is less complex and less costly than country‐wide elimination programmes and is an important first step in many settings. Preliminary data suggest that implementation of the World Health Organization (WHO) Global Health Sector Strategy on Viral Hepatitis can be cost saving. However, innovative financing mechanisms are needed to raise funds upfront for scaling up screening, treatment and harm reduction interventions that can lead to HCV elimination by 2030, the stated goal of the WHO. 相似文献
80.
Triantafyllos Stylianopoulos John D. Martin Vikash P. Chauhan Saloni R. Jain Benjamin Diop-Frimpong Nabeel Bardeesy Barbara L. Smith Cristina R. Ferrone Francis J. Hornicek Yves Boucher Lance L. Munn Rakesh K. Jain 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(38):15101-15108
The presence of growth-induced solid stresses in tumors has been suspected for some time, but these stresses were largely estimated using mathematical models. Solid stresses can deform the surrounding tissues and compress intratumoral lymphatic and blood vessels. Compression of lymphatic vessels elevates interstitial fluid pressure, whereas compression of blood vessels reduces blood flow. Reduced blood flow, in turn, leads to hypoxia, which promotes tumor progression, immunosuppression, inflammation, invasion, and metastasis and lowers the efficacy of chemo-, radio-, and immunotherapies. Thus, strategies designed to alleviate solid stress have the potential to improve cancer treatment. However, a lack of methods for measuring solid stress has hindered the development of solid stress-alleviating drugs. Here, we present a simple technique to estimate the growth-induced solid stress accumulated within animal and human tumors, and we show that this stress can be reduced by depleting cancer cells, fibroblasts, collagen, and/or hyaluronan, resulting in improved tumor perfusion. Furthermore, we show that therapeutic depletion of carcinoma-associated fibroblasts with an inhibitor of the sonic hedgehog pathway reduces solid stress, decompresses blood and lymphatic vessels, and increases perfusion. In addition to providing insights into the mechanopathology of tumors, our approach can serve as a rapid screen for stress-reducing and perfusion-enhancing drugs. 相似文献